VanEck Pharmaceutical ETF
140 hedge funds and large institutions have $544M invested in VanEck Pharmaceutical ETF in 2024 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 52 increasing their positions, 44 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
6% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 18
1% more funds holding
Funds holding: 139 → 140 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
140
Holding in Top 10
1
Calls
$1.2M
Puts
$694K
Top Buyers
| 1 | +$61.8M | |
| 2 | +$8.74M | |
| 3 | +$7.99M | |
| 4 |
AWC
Adamsbrown Wealth Consultants
Wichita,
Kansas
|
+$7.03M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$6.12M |
Top Sellers
| 1 | -$13.9M | |
| 2 | -$5.9M | |
| 3 | -$3.7M | |
| 4 |
PAG
Private Advisory Group
Redmond,
Washington
|
-$3.07M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.41M |